Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.41 |
| ▸ | MAPT | P10636 | 4/20 | 0.41 |
| ▸ | GAA | P10253 | 1/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.38 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.38 |
| ▸ | HPGD | P15428 | 7/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | TSHR | P16473 | 1/20 | 0.35 |
| ▸ | HTT | P42858 | 3/20 | 0.34 |
| ▸ | FGF23 | Q9GZV9 | 1/20 | 0.34 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | ACHE | P22303 | 1/20 | 0.32 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18508497 | 1.00 | ALDH1A1 (0.41) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL18508494 | 0.82 | L3MBTL1 (0.37) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL18502957 | 0.82 | L3MBTL1 (0.37) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL18508599 | 0.81 | L3MBTL1 (0.36) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL20148179 | 0.81 | HPGD (0.37) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL20150803 | 0.81 | HPGD (0.37) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL18302417 | 0.81 | L3MBTL1 (0.36) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL30683502 | 0.81 | L3MBTL1 (0.36) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL18502961 | 0.81 | L3MBTL1 (0.36) | ALDH1A1MAPTGAAL3MBTL1KDM4E | |
| SCHEMBL18502983 | 0.78 | ALDH1A1 (0.38) | ALDH1A1MAPTGAAL3MBTL1KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180134696-A1 | Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors | FORUM PHARMACEUTICALS, INC. | 2018-05-17 | — | — | US | disclosed |
| US-20170044155-A1 | Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors | AXOVANT SCIENCES GMBH (CH) | 2017-02-16 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170044155-A1 | Geminal Substituted Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors | CHRNA7, CHRNA5, CHRNA6 | ALDH1A1 2925/4885MAPT 1241/4885GAA 848/4885 |
| US-20180134696-A1 | Aminobenzisoxazole Compounds as Agonists of Alpha7-Nicotinic Acetylcholine Receptors | CHRNA7, CHRNA5, CHRNA2 | ALDH1A1 2821/4885MAPT 1008/4885GAA 1420/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.